Cardinal Health, Inc. (0HTG.L)
USD 149.2
(3.21%)
USD 149.2
(3.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 7.41 Billion USD | 7.62% |
| 2023 | 6.88 Billion USD | 5.26% |
| 2022 | 6.54 Billion USD | -3.44% |
| 2021 | 6.77 Billion USD | -1.31% |
| 2020 | 6.86 Billion USD | 0.5% |
| 2019 | 6.83 Billion USD | -4.83% |
| 2018 | 7.18 Billion USD | 9.73% |
| 2017 | 6.54 Billion USD | 0.02% |
| 2016 | 6.54 Billion USD | 14.55% |
| 2015 | 5.71 Billion USD | 10.68% |
| 2014 | 5.16 Billion USD | 4.88% |
| 2013 | 4.92 Billion USD | 8.37% |
| 2012 | 4.54 Billion USD | 9.11% |
| 2011 | 4.16 Billion USD | 10.09% |
| 2010 | 3.78 Billion USD | -31.59% |
| 2009 | 5.52 Billion USD | -1.91% |
| 2008 | 5.63 Billion USD | 7.41% |
| 2007 | 5.24 Billion USD | -0.67% |
| 2006 | 5.28 Billion USD | 5.48% |
| 2005 | 5 Billion USD | 5.6% |
| 2004 | 4.74 Billion USD | 5.13% |
| 2003 | 4.51 Billion USD | 11.46% |
| 2002 | 4.04 Billion USD | 12.03% |
| 2001 | 3.61 Billion USD | 15.28% |
| 2000 | 3.13 Billion USD | 11.02% |
| 1999 | 2.82 Billion USD | 155.19% |
| 1998 | 1.1 Billion USD | 15.65% |
| 1997 | 956.2 Million USD | 27.87% |
| 1996 | 747.8 Million USD | 53.96% |
| 1995 | 485.7 Million USD | 30.49% |
| 1994 | 372.2 Million USD | 177.76% |
| 1993 | 134 Million USD | 16.02% |
| 1992 | 115.5 Million USD | 32.61% |
| 1991 | 87.1 Million USD | 37.6% |
| 1990 | 63.3 Million USD | 25.84% |
| 1989 | 50.3 Million USD | 35.22% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.84 Billion USD | 4.41% |
| 2024 Q1 | 1.76 Billion USD | -3.23% |
| 2024 Q3 | 1.88 Billion USD | 2.0% |
| 2024 FY | 7.41 Billion USD | 7.62% |
| 2024 Q4 | 1.8 Billion USD | -3.93% |
| 2023 Q4 | 1.82 Billion USD | 2.35% |
| 2023 Q1 | 1.61 Billion USD | 0.56% |
| 2023 FY | 6.88 Billion USD | 5.26% |
| 2023 Q2 | 1.66 Billion USD | 3.04% |
| 2023 Q3 | 1.78 Billion USD | 7.34% |
| 2022 Q1 | 1.64 Billion USD | 11.32% |
| 2022 FY | 6.54 Billion USD | -3.44% |
| 2022 Q4 | 1.6 Billion USD | -4.58% |
| 2022 Q3 | 1.68 Billion USD | 4.08% |
| 2022 Q2 | 1.61 Billion USD | -1.58% |
| 2021 FY | 6.77 Billion USD | -1.31% |
| 2021 Q3 | 1.81 Billion USD | 2.03% |
| 2021 Q2 | 1.77 Billion USD | 3.56% |
| 2021 Q1 | 1.71 Billion USD | 7.86% |
| 2021 Q4 | 1.47 Billion USD | -18.6% |
| 2020 Q1 | 1.67 Billion USD | 0.3% |
| 2020 FY | 6.86 Billion USD | 0.5% |
| 2020 Q2 | 1.71 Billion USD | 2.08% |
| 2020 Q3 | 1.88 Billion USD | 9.98% |
| 2020 Q4 | 1.59 Billion USD | -15.65% |
| 2019 FY | 6.83 Billion USD | -4.83% |
| 2019 Q3 | 1.76 Billion USD | 1.97% |
| 2019 Q2 | 1.73 Billion USD | 3.78% |
| 2019 Q1 | 1.66 Billion USD | -3.92% |
| 2019 Q4 | 1.67 Billion USD | -5.1% |
| 2018 Q2 | 1.86 Billion USD | 11.3% |
| 2018 Q4 | 1.73 Billion USD | -9.3% |
| 2018 Q1 | 1.67 Billion USD | 3.02% |
| 2018 Q3 | 1.91 Billion USD | 2.79% |
| 2018 FY | 7.18 Billion USD | 9.73% |
| 2017 FY | 6.54 Billion USD | 0.02% |
| 2017 Q3 | 1.72 Billion USD | 7.87% |
| 2017 Q4 | 1.62 Billion USD | -6.08% |
| 2017 Q2 | 1.6 Billion USD | 0.75% |
| 2017 Q1 | 1.59 Billion USD | -4.5% |
| 2016 Q1 | 1.57 Billion USD | 8.3% |
| 2016 Q2 | 1.6 Billion USD | 1.9% |
| 2016 Q3 | 1.68 Billion USD | 4.97% |
| 2016 Q4 | 1.66 Billion USD | -1.42% |
| 2016 FY | 6.54 Billion USD | 14.55% |
| 2015 Q3 | 1.45 Billion USD | 0.34% |
| 2015 FY | 5.71 Billion USD | 10.68% |
| 2015 Q1 | 1.34 Billion USD | 6.77% |
| 2015 Q2 | 1.45 Billion USD | 8.43% |
| 2015 Q4 | 1.45 Billion USD | -0.07% |
| 2014 FY | 5.16 Billion USD | 4.88% |
| 2014 Q3 | 1.29 Billion USD | -3.57% |
| 2014 Q2 | 1.34 Billion USD | 6.41% |
| 2014 Q4 | 1.25 Billion USD | -3.16% |
| 2014 Q1 | 1.26 Billion USD | 1.36% |
| 2013 FY | 4.92 Billion USD | 8.37% |
| 2013 Q4 | 1.24 Billion USD | -3.41% |
| 2013 Q3 | 1.29 Billion USD | 5.47% |
| 2013 Q2 | 1.22 Billion USD | 5.61% |
| 2013 Q1 | 1.15 Billion USD | 2.02% |
| 2012 FY | 4.54 Billion USD | 9.11% |
| 2012 Q4 | 1.13 Billion USD | -5.86% |
| 2012 Q3 | 1.2 Billion USD | 8.33% |
| 2012 Q2 | 1.11 Billion USD | 2.71% |
| 2012 Q1 | 1.08 Billion USD | 3.95% |
| 2011 Q3 | 1.16 Billion USD | 16.9% |
| 2011 Q2 | 994.2 Million USD | 3.33% |
| 2011 FY | 4.16 Billion USD | 10.09% |
| 2011 Q4 | 1.04 Billion USD | -10.23% |
| 2011 Q1 | 962.2 Million USD | 6.43% |
| 2010 FY | 3.78 Billion USD | -31.59% |
| 2010 Q2 | 957.7 Million USD | 5.38% |
| 2010 Q4 | 904.1 Million USD | -10.49% |
| 2010 Q3 | 1.01 Billion USD | 5.47% |
| 2010 Q1 | 908.8 Million USD | -32.37% |
| 2009 Q4 | 1.34 Billion USD | -4.13% |
| 2009 FY | 5.52 Billion USD | -1.91% |
| 2009 Q2 | 1.41 Billion USD | 3.8% |
| 2009 Q3 | 1.4 Billion USD | -1.04% |
| 2009 Q1 | 1.36 Billion USD | -7.14% |
| 2008 Q3 | 1.46 Billion USD | 8.36% |
| 2008 Q2 | 1.35 Billion USD | 0.92% |
| 2008 Q4 | 1.46 Billion USD | 0.11% |
| 2008 FY | 5.63 Billion USD | 7.41% |
| 2008 Q1 | 1.34 Billion USD | -1.13% |
| 2007 Q1 | 1.29 Billion USD | -9.0% |
| 2007 Q2 | 1.29 Billion USD | 0.08% |
| 2007 Q3 | 1.38 Billion USD | 6.74% |
| 2007 FY | 5.24 Billion USD | -0.67% |
| 2007 Q4 | 1.35 Billion USD | -2.16% |
| 2006 Q1 | 1.21 Billion USD | -11.23% |
| 2006 FY | 5.28 Billion USD | 5.48% |
| 2006 Q4 | 1.42 Billion USD | 4.25% |
| 2006 Q3 | 1.36 Billion USD | 4.74% |
| 2006 Q2 | 1.3 Billion USD | 7.75% |
| 2005 Q3 | 1.34 Billion USD | 11.63% |
| 2005 Q2 | 1.2 Billion USD | 11.04% |
| 2005 Q1 | 1.08 Billion USD | -9.95% |
| 2005 FY | 5 Billion USD | 5.6% |
| 2005 Q4 | 1.36 Billion USD | 1.48% |
| 2004 Q2 | 1.17 Billion USD | 8.08% |
| 2004 Q1 | 1.08 Billion USD | -11.9% |
| 2004 Q3 | 1.28 Billion USD | 9.4% |
| 2004 FY | 4.74 Billion USD | 5.13% |
| 2004 Q4 | 1.2 Billion USD | -5.8% |
| 2003 FY | 4.51 Billion USD | 11.46% |
| 2003 Q4 | 1.22 Billion USD | 2.96% |
| 2003 Q1 | 1 Billion USD | -5.23% |
| 2003 Q2 | 1.07 Billion USD | 7.21% |
| 2003 Q3 | 1.19 Billion USD | 10.62% |
| 2002 Q4 | 1.06 Billion USD | -0.56% |
| 2002 Q3 | 1.06 Billion USD | 6.8% |
| 2002 Q2 | 1 Billion USD | 9.38% |
| 2002 Q1 | 914.7 Million USD | -6.27% |
| 2002 FY | 4.04 Billion USD | 12.03% |
| 2001 Q4 | 975.9 Million USD | 3.15% |
| 2001 Q2 | 809 Million USD | 9.86% |
| 2001 Q3 | 946.1 Million USD | 16.95% |
| 2001 Q1 | 736.4 Million USD | -10.67% |
| 2001 FY | 3.61 Billion USD | 15.28% |
| 2000 Q1 | 716.5 Million USD | -5.11% |
| 2000 Q4 | 824.4 Million USD | 11.48% |
| 2000 FY | 3.13 Billion USD | 11.02% |
| 2000 Q3 | 739.5 Million USD | -5.86% |
| 2000 Q2 | 785.5 Million USD | 9.63% |
| 1999 Q2 | 408.7 Million USD | 26.3% |
| 1999 Q3 | 789.9 Million USD | 93.27% |
| 1999 Q4 | 755.1 Million USD | -4.41% |
| 1999 FY | 2.82 Billion USD | 155.19% |
| 1999 Q1 | 323.6 Million USD | 6.38% |
| 1998 Q2 | 264.6 Million USD | 11.32% |
| 1998 Q4 | 304.2 Million USD | 2.77% |
| 1998 FY | 1.1 Billion USD | 15.65% |
| 1998 Q1 | 237.7 Million USD | -6.01% |
| 1998 Q3 | 296 Million USD | 11.87% |
| 1997 Q4 | 252.9 Million USD | -3.47% |
| 1997 Q3 | 262 Million USD | 20.52% |
| 1997 Q1 | 190.7 Million USD | -38.7% |
| 1997 Q2 | 217.4 Million USD | 14.0% |
| 1997 FY | 956.2 Million USD | 27.87% |
| 1996 Q1 | 124.1 Million USD | -2.9% |
| 1996 Q3 | 157.7 Million USD | 10.28% |
| 1996 Q2 | 143 Million USD | 15.23% |
| 1996 Q4 | 311.1 Million USD | 97.27% |
| 1996 FY | 747.8 Million USD | 53.96% |
| 1995 Q4 | 127.8 Million USD | -3.03% |
| 1995 Q1 | 108.6 Million USD | 8.06% |
| 1995 Q3 | 131.8 Million USD | 12.07% |
| 1995 Q2 | 117.6 Million USD | 8.29% |
| 1995 FY | 485.7 Million USD | 30.49% |
| 1994 FY | 372.2 Million USD | 177.76% |
| 1994 Q1 | 37.7 Million USD | 8.33% |
| 1994 Q3 | 102.5 Million USD | 154.98% |
| 1994 Q2 | 40.2 Million USD | 6.63% |
| 1994 Q4 | 100.5 Million USD | -1.95% |
| 1993 Q1 | 31 Million USD | -4.02% |
| 1993 FY | 134 Million USD | 16.02% |
| 1993 Q4 | 34.8 Million USD | -7.2% |
| 1993 Q3 | 37.5 Million USD | 13.64% |
| 1993 Q2 | 33 Million USD | 6.45% |
| 1992 Q2 | 30.1 Million USD | 23.36% |
| 1992 Q3 | 36.8 Million USD | 22.26% |
| 1992 FY | 115.5 Million USD | 32.61% |
| 1992 Q1 | 24.4 Million USD | 1.24% |
| 1992 Q4 | 32.3 Million USD | -12.23% |
| 1991 Q2 | 22.8 Million USD | 13.43% |
| 1991 Q4 | 24.1 Million USD | -10.41% |
| 1991 Q1 | 20.1 Million USD | 18.24% |
| 1991 Q3 | 26.9 Million USD | 17.98% |
| 1991 FY | 87.1 Million USD | 37.6% |
| 1990 Q3 | 19.1 Million USD | 24.84% |
| 1990 FY | 63.3 Million USD | 25.84% |
| 1990 Q1 | -10.4 Million USD | -105.12% |
| 1990 Q4 | 17 Million USD | -10.99% |
| 1990 Q2 | 15.3 Million USD | 247.12% |
| 1989 FY | 50.3 Million USD | 35.22% |
| 1989 Q3 | 198.2 Million USD | 8.42% |
| 1989 Q2 | 182.8 Million USD | -7.77% |
| 1989 Q1 | 198.2 Million USD | 27.87% |
| 1989 Q4 | 203.3 Million USD | 2.57% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -3574.936% |
| Accuray Incorporated | 143.12 Million USD | -5080.232% |
| Align Technology, Inc. | 2.72 Billion USD | -172.557% |
| Elevance Health Inc. | 47.01 Billion USD | 84.229% |
| AxoGen, Inc. | 127.87 Million USD | -5697.895% |
| Boston Scientific Corporation | 9.84 Billion USD | 24.723% |
| CVS Health Corporation | 54.43 Billion USD | 86.379% |
| Centene Corporation | 153.99 Billion USD | 95.186% |
| DaVita Inc. | 3.82 Billion USD | -94.062% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 86.536% |
| Hologic, Inc. | 2.23 Billion USD | -231.308% |
| Humana Inc. | 106.44 Billion USD | 93.035% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -238.543% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -120.333% |
| Masimo Corporation | 1 Billion USD | -638.814% |
| McKesson Corporation | 12.58 Billion USD | 41.084% |
| Patterson Companies, Inc. | 1.38 Billion USD | -437.152% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -150.388% |
| ResMed Inc. | 2.6 Billion USD | -184.194% |
| Henry Schein, Inc. | 3.65 Billion USD | -103.068% |
| Teladoc Health, Inc. | 1.84 Billion USD | -302.413% |
| Universal Health Services, Inc. | 1.17 Billion USD | -530.774% |
| Veeva Systems Inc. | 1.68 Billion USD | -339.639% |
| Baxter International Inc. | 4.97 Billion USD | -49.025% |
| Becton, Dickinson and Company | 8.82 Billion USD | 15.97% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -56.761% |
| Danaher Corporation | 14.12 Billion USD | 47.526% |
| Stryker Corporation | 13.05 Billion USD | 43.223% |
| Medtronic plc | 21.27 Billion USD | 65.148% |